Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 Jun;35(6):661–666. doi: 10.1136/jcp.35.6.661

Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.

V Chan, C K Yeung, T K Chan
PMCID: PMC497746  PMID: 7085916

Abstract

Plasma antithrombin III (AtIII), serum fragment E (FgE) and urine AtIII and FgE were measured in 25 diabetic patients with proteinuria above 1 g per day and compared to that in 25 patients with non-diabetic nephropathy, matched for the degree of proteinuria. Plasma AtIII concentrations were normal in both groups but FgE concentrations were increased. The level of plasma AtIII was directly related to HbA1 concentrations in the diabetics. For the same degree of proteinuria, the diabetic patients lost more AtIII and FgE in the urine. Urine AtIII was found to be mostly bound to activated procoagulants. Both urine AtIII and urine FgE correlated inversely with creatinine clearance. It was concluded that intraglomerular thrombosis probably contributes to the deteriorating renal function in diabetic nephropathy and is reflected in the concentrations of urine AtIII and FgE.

Full text

PDF
661

Images in this article

664Image
on p.664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chan T. K., Chan V. The effect of venous occlusion on antithrombin III, plasminogen activator and fibrinogen degradation product (fragment E) levels. Thromb Res. 1979;14(4-5):525–534. doi: 10.1016/0049-3848(79)90108-7. [DOI] [PubMed] [Google Scholar]
  2. Chan V., Chan T. K. Antithrombin III in fresh and cultured human endothelial cells: a natural anticoagulant from the vascular endothelium. Thromb Res. 1979;15(1-2):209–213. doi: 10.1016/0049-3848(79)90066-5. [DOI] [PubMed] [Google Scholar]
  3. Chan V., Chan T. K. Heparin-antithrombin III binding. In vitro and in vivo studies. Haemostasis. 1979;8(6):373–389. doi: 10.1159/000214328. [DOI] [PubMed] [Google Scholar]
  4. Chan V., Chan T. K., Wong V., Tso S. C., Todd D. The determination of antithrombin III by radioimmunoassay and its clinical application. Br J Haematol. 1979 Apr;41(4):563–572. doi: 10.1111/j.1365-2141.1979.tb05893.x. [DOI] [PubMed] [Google Scholar]
  5. Clarkson A. R., MacDonald M. K., Petrie J. J., Cash J. D., Robson J. S. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis. Br Med J. 1971 Aug;3(5772):447–451. doi: 10.1136/bmj.3.5772.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farquhar A., MacDonald M. K., Ireland J. T. The role of fibrin deposition in diabetic glomerulosclerosis: a light, electron and immunofluorescence microscopy study. J Clin Pathol. 1972 Aug;25(8):657–667. doi: 10.1136/jcp.25.8.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GELLMAN D. D., PIRANI C. L., SOOTHILL J. F., MUEHRCKE R. C., KARK R. M. Diabetic nephropathy: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 1959 Dec;38:321–367. [PubMed] [Google Scholar]
  8. Gabbay K. H., Hasty K., Breslow J. L., Ellison R. C., Bunn H. F., Gallop P. M. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab. 1977 May;44(5):859–864. doi: 10.1210/jcem-44-5-859. [DOI] [PubMed] [Google Scholar]
  9. Gordon Y. B., Martin M. J., Landon J., Chard T. The development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol. 1975 Jan;29(1):109–119. doi: 10.1111/j.1365-2141.1975.tb01804.x. [DOI] [PubMed] [Google Scholar]
  10. Jerums G., Post R. S., Miller M., Barzellato E. Differential renal protein clearance in diabetes. Diabetes. 1973 Feb;22(2):104–110. doi: 10.2337/diab.22.2.104. [DOI] [PubMed] [Google Scholar]
  11. Jones R. H., Hayakawa H., Mackay J. D., Parsons V., Watkins P. J. Progression of diabetic nephropathy. Lancet. 1979 May 26;1(8126):1105–1106. doi: 10.1016/s0140-6736(79)91788-4. [DOI] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lee A. K., Chan V., Chan T. K. The identification and localization of antithrombin III in human tissues. Thromb Res. 1979 Jan;14(1):209–217. doi: 10.1016/0049-3848(79)90039-2. [DOI] [PubMed] [Google Scholar]
  14. Osterby R. Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia. 1972 Apr;8(2):84–92. doi: 10.1007/BF01235631. [DOI] [PubMed] [Google Scholar]
  15. Pirart J. Diabète et complications dégénératives présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. (Première partie). Diabete Metab. 1977 Jun;3(2):97–107. [PubMed] [Google Scholar]
  16. Steffes M. W., Brown D. M., Mauer S. M. The development, enhancement, and reversal of the secondary complications of diabetes mellitus. Hum Pathol. 1979 May;10(3):293–299. doi: 10.1016/s0046-8177(79)80026-x. [DOI] [PubMed] [Google Scholar]
  17. Stiehm E. R., Trygstad C. W. Split products of fibrin in human renal disease. Am J Med. 1969 May;46(5):774–786. doi: 10.1016/0002-9343(69)90028-x. [DOI] [PubMed] [Google Scholar]
  18. Takazakura E., Nakamoto Y., Hayakawa H., Kawai K., Muramoto S. Onset and progression of diabetic glomerulosclerosis; a prospective study based on serial renal biopsies. Diabetes. 1975 Jan;24(1):1–9. doi: 10.2337/diab.24.1.1. [DOI] [PubMed] [Google Scholar]
  19. Viberti G. C., Keen H., Mackintosh D. Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) 1981 Jan 10;282(6258):95–98. doi: 10.1136/bmj.282.6258.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Watkins P. J., Blainey J. D., Brewer D. B., Fitzgerald M. G., Malins J. M., O'Sullivan D. J., Pinto J. A. The natural history of diabetic renal disease. A follow-up study of a series of renal biopsies. Q J Med. 1972 Oct;41(164):437–456. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES